Portal Instruments Advances PRIME NEXUS™ with New Development Agreement for Clinical Readiness Portal Instruments has signed a major agreement to further develop its PRIME NEXUS™, a groundbreaking autoinjector, preparing it for clinical use by 2027.

Portal Instruments Advances PRIME NEXUS™ with New Development Agreement for Clinical Readiness #USA #Boston #Drug_Delivery #PRIME_NEXUS™ #Portal_Instruments